Back

Association between fibrinogen and clot strength and their prognostic implications after percutaneous coronary intervention

29 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Coronary and structural interventions: technical strategies and prognostic factors Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Gyu Tae Park

Chung-Ang University Hospital, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Drug-coated balloon–only strategy versus drug-eluting stents in large-vessel complex PCI: a propensity-matched 3-year outcome analysis
Doctor R. Bando (Tokushima, JP)
Abstract Slides Video
Presentation thumbnail
Female vs male complex PCI by sirolimus-eluting stenting: one-year NAGOMI COMPLEX study outcome
Doctor A. Aminian (Charleroi, BE) Professor M. Mamas (Keele, GB)
Abstract Slides Video
Presentation thumbnail
Selective PCI for high-risk non-ischemic lesions: a viable strategy with long-term benefit
Doctor H. Xuan (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Long term outcomes of left main stem trifurcation PCI compared to left main stem bifurcation anatomy
Doctor H. Khan (Newcastle-Upon-Tyne, GB)
Abstract Slides Video
Presentation thumbnail
Reporting of periprocedural myocardial infarctions in coronary intervention trials: a systematic review
Assistant Professor C. Baillie (New York, US)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary and structural interventions: technical strategies and prognostic factors

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between genetic polymorphisms in multiple thrombosis-related genes and long-term prognosis in coronary artery disease patients: a large-scale cohort study
1 September 2025
thumbnail
Congress Presentation
Periprocedural assessment of coronary microcirculatory function to predict clinical outcomes after elective PCI
1 September 2025
thumbnail
Congress Presentation
Edoxaban in atrial fibrillation with PCI by ACS or stable CAD presentation: a pre-specified analysis of the ENTRUST-AF PCI trial
28 August 2020
thumbnail
Congress Presentation
Thrombelastography identifies patients at risk for major adverse cardiovascular events after transcatheter aortic valve implantation
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources